3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
5
Heart Diseases
3
Carcinoma, Non-Small-Cell Lung
3
Vascular Diseases
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Small Cell Lung Carcinoma
1
Metabolic Diseases
1
Liver Neoplasms
1
Hematologic Neoplasms
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Cancer Therapy-related Cardiovascular Toxicity
1
Interventions
Echocardiography
3
Electrocardiography
2
Blood Specimen Collection
2
ziprasidone
1
Zolpidem
1
Watchful Waiting
1
Warfarin
1
Vecuronium Bromide
1
Vascular Stiffness
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Surveys and Questionnaires
1
Standard of Care
1
Spironolactone
1
Specimen Handling
1
Sevelamer
1
Rocuronium
1
Pulse Wave Analysis
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Lenalidomide
1
Labetalol
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Heart Failure
×
Antineoplastic Agents
×
Clear all
NCT03882580
2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
5,000 enrolled